Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists.

被引：0
|
作者：
vanRhee, AM
Siddiqi, SM
Melman, N
Shi, D
Padgett, WL
Daly, JW
Jacobson, KA
机构：
[1] NIDDK,NIH,LBC,MOL RECOGNIT SECT,BETHESDA,MD 20892
[2] NIDDK,NIH,LBC,PHARMACODYNAM SECT,BETHESDA,MD 20892
来源：
FASEB JOURNAL | 1996年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：784 / 784
页数：1
相关论文
共 50 条
  • [41] Ethenesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists
    Harada, H
    Kazami, J
    Watanuki, S
    Tsuzuki, R
    Sudoh, K
    Fujimori, A
    Tanaka, A
    Tsukamoto, S
    Yanagisawa, I
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (05) : 606 - 612
  • [42] Novel H3 receptor antagonists.: Sulfonamide homologs of histamine
    Wolin, R
    Connolly, M
    Afonso, A
    Hey, JA
    She, H
    Rivelli, MA
    Willams, SM
    West, RE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (16) : 2157 - 2162
  • [43] Diarylamidines and -imidazolines as NMDA receptor antagonists.
    Zhang, Q
    Huang, TL
    Sharma, TA
    Reynolds, IJ
    Donkor, IO
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U234 - U234
  • [44] Cyclic peptides as VEGF receptor antagonists.
    Goncalves, V.
    Gautier, B.
    Garbay, C.
    Vidal, M.
    Inguimbert, N.
    BIOPOLYMERS, 2007, 88 (04) : 541 - 541
  • [45] BENZIMIDAZOLE DERIVATIVES AS NOVEL SEROTONIN 5-HT6 RECEPTOR ANTAGONISTS. A COMPUTATIONAL AND MUTAGENESIS STUDY OF LIGAND-RECEPTOR INTERACTION
    Martin-Fontecha, Mar
    Benhamu, Bellinda
    de la Fuente, Tania
    Sallander, Jessica
    Campillo, Mercedes
    Vazquez-Villa, Henar
    Pellisier, Lucie
    Claeysen, Sylvie
    Dumuis, Aline
    Pardo, Leonardo
    Lopez-Rodriguez, Maria L.
    DRUGS OF THE FUTURE, 2009, 34 : 217 - 217
  • [46] Novel triazolopyrazine, triazolopyrimidine, and triazolotriazine derivatives as potent and selective adenosine A2a receptor antagonists
    Kumaravel, Gnanasambandam
    Engber, Thomas
    Vu, Chi B.
    Peng, Hairuo
    Dowling, James E.
    Yao, Gang
    Vessels, Jeffery T.
    Scott, Daniel
    Petter, Russell C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [47] Pharmacophore based receptor modeling:: The case of adenosine A3 receptor antagonists.: An approach to the optimization of protein models
    Tafi, Andrea
    Bernardini, Cesare
    Botta, Maurizio
    Corelli, Federico
    Andreini, Matteo
    Martinelli, Adriano
    Ortore, Gabriella
    Baraldi, Pier Giovanni
    Fruttarolo, Francesca
    Borea, Pier Andrea
    Tuccinardi, Tiziano
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) : 4085 - 4097
  • [48] Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists.: 1.: Bicyclo[2.2.1]heptane derivatives
    Mitsumori, S
    Tsuri, T
    Honma, T
    Hiramatsu, Y
    Okada, T
    Hashizume, H
    Inagaki, M
    Arimura, A
    Yasui, K
    Asanuma, F
    Kishino, J
    Ohtani, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (12) : 2436 - 2445
  • [49] Novel derivatives of tolterodine in hunt for M3 selective muscarinic antagonists.
    Kumar, N
    Sarma, PKS
    Kaur, K
    Aeron, S
    Dutt, A
    Bruhaspathy, M
    Shetty, S
    Gupta, S
    Chugh, A
    Gupta, JB
    Mehta, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U58 - U58
  • [50] Novel N-(thiazolyl-5-carbonyl)-β-alanine derivatives as potent, orally active fibrinogen receptor antagonists.
    Carceller, E
    Gomez, LA
    Merlos, M
    Garcia-Rafanell, J
    Forn, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U225 - U225
12345